Advertisement

Neurochemical Research

, Volume 25, Issue 3, pp 327–334 | Cite as

C-fos mRNA Induction in the Central and Peripheral Nervous Systems of Diisopropyl Phosphorofluoridate (DFP)-Treated Hens

  • Ram P. Gupta
  • Tirupapuliyur V. Damodaran
  • Mohamed B. Abou-Donia
Article

Abstract

A single dose of diisopropyl phosphorofluoridate (DFP), an organophosphorus ester, produces delayed neurotoxicity (OPIDN) in hen. DFP produces mild ataxia in hens in 7–14 days, which develops into severe ataxia or paralysis as the disease progresses. Since, OPIDN is associated with alteration in the expression of several proteins (e.g., Ca2+/calmodulin-dependent protein kinase II (CaM kinase II) α-subunit, tau, tubulin, neurofilament (NF) protein, vimentin, GFAP) as well as their mRNAs (e.g., NF, CaM kinase II α-subunit), we determined the effect of a single dose of DFP on the expression of one of the best known immediate-early gene (IEG), c-fos. C-fos expression was measured by Northern hybridization in cerebrum, cerebellum, brainstem, midbrain, spinal cord, and the sciatic nerves of hens at 0.5 hr, 1 hr, 2 hr, 1 day, 5 days, 10 days, and 20 days after a single 1.7 mg/kg, sc. injection of DFP. All the tissues (cerebrum, 52%; cerebellum, 55%; brainstem, 49%; midbrain, 23%; spinal cord, 80%; sciatic nerve, 157%;) showed significant increase in c-fos expression in 30 min and this elevated level persisted at least up to 2 hr. Expressions of β-actin mRNA and 18S RNA were used as internal controls. The significant increase in c-fos expression in DFP-treated hens suggests that c-fos may be one of the IEGs involved in the development of OPIDN.

Diisopropyl phosphorofluoridate c-fos brain spinal cord sciatic nerve chicken 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Abou-Donia, M. B. 1995. Organophosphorus Pesticides. Pages 419-474, in Chang, L. W. and Dyer, R. S. (eds.). Handbook of Neurotoxicology. Mercel Dekker, Inc., New York.Google Scholar
  2. 2.
    Abou-Donia, M. B. 1981. Organophosphorus ester-induced delayed neurotoxicity. Annu. Rev. Pharmacol. Toxicol. 21:511–548.Google Scholar
  3. 3.
    Abou-Donia, M. B. and Lapadula, D. M. 1990. Mechanisms of organophosphorus ester-induced delayed neurotoxicity: Type I and Type II. Annu. Rev. Pharmacol. Toxicol. 30:405–440.Google Scholar
  4. 4.
    Bischoff, A. 1967. The ultrastructure of Tri-ortho-cresyl phosphate-poisoning. I. Studies on myelin and axonal alterations in the sciatic nerve. Acta Neuropathol. 9:158–174.Google Scholar
  5. 5.
    Bischoff, A. 1970. Ultrastructure of Tri-ortho-cresyl phosphate poisoning in the chicken. II. Studies on spinal cord alterations. Acta Neuropath. (Berl.) 15:142–155.Google Scholar
  6. 6.
    Funk, K. A., Henderson, J. D., Liu, C.-H., Higgins, R. J., and Wilson, B. W. 1994. Neuropathology of organophosphate-induced delayed neuropathy (OPIDN) in young chicks. Arch. Toxicol. 68: 308–316.Google Scholar
  7. 7.
    Jensen, K. F., Lapadula, D. M., Anderson, J. K., Haykal-Coates, N., and Abou-Donia, M. B. 1992. Anomalous phosphorylated neurofilament aggregations in central and peripheral axons of hens treated with tri-ortho-cresyl phosphate (TOCP). J. Neurosci. Res. 33:455–460.Google Scholar
  8. 8.
    Abou-Donia, M. B., Viana, M. E., Gupta, R. P., and Anderson, J. K. 1993. Enhanced calmodulin binding concurrent with increased kinase-dependent phosphorylation of cytoskeletal proteins following a single subcutaneous injection of diisopropyl phosphorofluoridate in hens. Neurochem. Int. 22:165–173.Google Scholar
  9. 9.
    Gupta, R. P., Bing, G., Hong, J.-S., and Abou-Donia, M. B. 1998. cDNA cloning and sequencing of Ca2+/calmodulin-dependent protein kinase II? subunit and its mRNA expression in diisopropyl phosphorofluoridate (DFP)-treated hen central nervous system. Mol. Cell. Biochem. 181:29–39.Google Scholar
  10. 10.
    Gupta, R. P., Lin, W. W., and Abou-Donia, M. B. 1999. Enhanced mRNA expression of neurofilament subunits in the brain and spinal cord of diisopropyl phosphorofluoridate-treated hens. Biochem. Pharmacol. 57:1245–1251.Google Scholar
  11. 11.
    Herdegen, T. and Leah, J. D. 1998. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Rev. 28:370–490.Google Scholar
  12. 12.
    Harris, J. A. 1998. Using c-fos as a neural marker of pain. Brain Res. Bull. 45:1–8.Google Scholar
  13. 13.
    Levine, M. and Manley, J. L. 1989. Transcriptional repression of eukaryotic promoters. Cell 59:405–408.Google Scholar
  14. 14.
    Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. 1995. Current Protocols in Molecular Biology. John Wiley, New York.Google Scholar
  15. 15.
    Kaufer, D., Friedman, A., Seidman, S., and Soreq, H. 1998. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393:373–377.Google Scholar
  16. 16.
    Harvey, M. J. and Sharma, R. P. 1980. Organophosphate cytotoxicity: the effect on protein metabolism in cultured neuroblastoma cells. J. Environ. Pathol. Toxicol. 3:423–436.Google Scholar
  17. 17.
    Pope, C., deLorenzo, K., and Ehrich, M. 1995. Possible involvement of a neurotrophic factor during the early stages of organophosphate-induced delayed neurotoxicity. Toxicol. Lett. 75: 111–117.Google Scholar
  18. 18.
    Myslivecek, J., Trojan, S., and Tucek, S. 1996. Biphasic changes in the density of muscarinic and beta-adrenergic receptors in cardiac atria of rats treated with diisopropylfluorophosphate. Life Sci. 58:2423–2430.Google Scholar
  19. 19.
    Herdegen, T., Fiallos-Estrada, C., Schmid, W., Bravo, R. and Zimmermann, M. 1992. The transaction factor CREB, but not immediate-early gene encoded proteins, is expressed in activated microglia of lumber spinal cord following sciatic nerve transection in the rat. Neurosci. Lett. 142:57–61.Google Scholar
  20. 20.
    Herrera, D. G. and Robertson, H. A. 1996. Activation of c-fos in the brain. Prog. Neurobiol. 50:83–107.Google Scholar
  21. 21.
    Gupta, R. P. and Abou-Donia, M. B. 1995. Diisopropyl phosphorofluoridate (DFP) treatment alters calcium-activated proteinase activity and cytoskeletal proteins of the hen sciatic nerve. Brain Res. 677:162–166.Google Scholar
  22. 22.
    Shemshedini, L., Knauthe, R., Sassone-Corsi, P., Pornon, A., and Gronemeyer, H. 1991. Cell-specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors. EMBO J. 10:3839–3849.Google Scholar
  23. 23.
    Liu, H. M., Yang, L. H., and Yang, Y. J. 1995. Schwann cell properties: 3. C-fos expression, bFGF production, phagocytosis and proliferation during Wallerian degeneration. J. Neuropathol. Exp. Neurol. 54:487–496.Google Scholar
  24. 24.
    Pyykonen, I., and Koistinaho, J. 1991. c-fos protein like immunoreactivity in non-neuronal cells of rat peripheral nerve after transection. Acta Neuropathol (Berl) 82:66–71.Google Scholar
  25. 25.
    Hirakawa, M. and Kawata, M. 1992. Distribution pattern of c-Fos expression induced by sciatic nerve sectioning in the rat central nervous system J. Hirnforsch. 34:431–444.Google Scholar
  26. 26.
    Plantinga, L. C., Verhaagen, J., Wong, S. L., Edwards, P. M., Bar, P. R., and Gispen, W. H. 1994. The neurotrophic peptide org 2766 does not influence the expression of the immediate early gene c-fos following sciatic nerve crush in the rat. Int. J. Dev. Neurosci. 12:117–125.Google Scholar
  27. 27.
    Endo, H., Sabri, M. I., Stephens, J. M., Pekala, P. H. and Kittur, S. 1993. Acrylamide induces immediate-early gene expression in rat brain. Brain Res. 609:231–236.Google Scholar
  28. 28.
    Hayward, M. D., Duman, R. S., and Nestler, E. J. 1990. Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brain. Brain Res. 525: 256–266.Google Scholar
  29. 29.
    Kovacs, K. J. 1998. c-Fos as a transcription factor: a stressful review from a functional map. Neurochem. Int. 33:287–297.Google Scholar

Copyright information

© Plenum Publishing Corporation 2000

Authors and Affiliations

  • Ram P. Gupta
    • 1
  • Tirupapuliyur V. Damodaran
    • 1
  • Mohamed B. Abou-Donia
    • 2
  1. 1.Department of Pharmacology and Cancer BiologyDuke University Medical CenterDurham
  2. 2.Department of Pharmacology and Cancer BiologyDuke University Medical CenterDurham

Personalised recommendations